China Resources Shuanghe: A wholly-owned subsidiary, Balanced Salt Solution, has obtained a drug registration certificate.

China Resources Double Crane announced that its wholly-owned subsidiary, Jingxi Double Crane, has received the "Drug Registration Certificate" for balanced salt irrigation solution issued by the National Medical Products Administration, approving its listing. The drug is a sterile electrolyte water solution, suitable for surgical irrigation, considered to have passed consistency evaluation. Jingxi Double Crane started research and development in January 2022 and was approved in February 2026. As of the announcement date, the cumulative research and development investment totaled 3.6531 million yuan. The global sales of this drug in 2024 amounted to 3.3442 million US dollars, with total domestic market sales of 55.85 million yuan. The approval of this drug will enrich the company's product line, enhance competitiveness, but sales performance has uncertainties.